Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients-Reference-Cited by-同舟云学术

Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients

Published:2009-02 Issue:2 Volume:63 Page:251-258
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Gebbia Vittorio,Gridelli Cesare,Verusio Claudio,Frontini Luciano,Aitini Enrico,Daniele Bruno,Gamucci Teresa,Mancuso Gianfranco,Di Maio Massimo,Gallo Ciro,Perrone Francesco,Morabito Alessandro

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Non Small Cell Lung Cancer Collaborative Group;BMJ,1995

2. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

3. Non-small cell lung cancer clinical practice guidelines in oncology;Ettinger;J Natl Compr Canc Netw,2006

4. Prospective randomized trial of docetaxel versus best supportive care in patients with Non-Small-Cell Lung Cancer previously treated with platinum-based chemotherapy;Shepherd;J Clin Oncol,2000

5. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with Non-Small Cell Lung Cancer previously treated with platinum-containing chemotherapy regimens;Fossella;J Clin Oncol,2000

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials;ESMO Open;2024-03

2. Therapeutic strategies for non-small cell lung cancer: Experimental models and emerging biomarkers to monitor drug efficacies;Pharmacology & Therapeutics;2023-02

3. CURRENT THERAPEUTIC STRATEGIES AND CHALLENGES IN NSCLC TREATMENT: A COMPREHENSIVE REVIEW;Experimental Oncology;2022-05-20

4. Comparison between single-agent and combination chemotherapy as second-line treatment for advanced non-small cell lung cancer: a multi-institutional retrospective analysis;Cancer Chemotherapy and Pharmacology;2020-06-12